A detailed history of Capital Research Global Investors transactions in Stryker Corp stock. As of the latest transaction made, Capital Research Global Investors holds 9,982,717 shares of SYK stock, worth $3.4 Billion. This represents 0.83% of its overall portfolio holdings.

Number of Shares
9,982,717
Previous 10,205,488 2.18%
Holding current value
$3.4 Billion
Previous $3.06 Billion 16.9%
% of portfolio
0.83%
Previous 0.77%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$293.94 - $358.71 $65.5 Million - $79.9 Million
-222,771 Reduced 2.18%
9,982,717 $3.57 Billion
Q4 2023

Feb 13, 2024

SELL
$253.85 - $299.46 $33.3 Million - $39.2 Million
-131,032 Reduced 1.27%
10,205,488 $3.06 Billion
Q3 2023

Nov 13, 2023

SELL
$266.54 - $302.43 $1.07 Billion - $1.22 Billion
-4,017,483 Reduced 27.99%
10,336,520 $2.82 Billion
Q2 2023

Aug 11, 2023

SELL
$271.49 - $305.09 $454 Million - $510 Million
-1,672,417 Reduced 10.44%
14,354,003 $4.38 Billion
Q1 2023

May 15, 2023

BUY
$246.13 - $285.47 $480 Million - $557 Million
1,949,794 Added 13.85%
16,026,420 $4.58 Billion
Q4 2022

Feb 14, 2023

BUY
$205.51 - $253.93 $297 Million - $367 Million
1,443,660 Added 11.43%
14,076,626 $3.44 Billion
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $356 Million - $436 Million
1,879,256 Added 17.48%
12,632,966 $2.56 Billion
Q2 2022

Aug 15, 2022

BUY
$194.09 - $276.37 $67.9 Million - $96.7 Million
350,042 Added 3.36%
10,753,710 $2.14 Billion
Q1 2022

May 16, 2022

BUY
$245.33 - $277.77 $123 Million - $140 Million
502,935 Added 5.08%
10,403,668 $2.78 Billion
Q4 2021

Feb 14, 2022

BUY
$236.63 - $276.44 $33.2 Million - $38.8 Million
140,504 Added 1.44%
9,900,733 $2.65 Billion
Q3 2021

Nov 15, 2021

BUY
$248.9 - $280.09 $103 Million - $116 Million
415,448 Added 4.45%
9,760,229 $2.57 Billion
Q2 2021

Aug 16, 2021

SELL
$242.95 - $267.0 $36.4 Million - $40 Million
-149,820 Reduced 1.58%
9,344,781 $2.43 Billion
Q1 2021

May 14, 2021

BUY
$221.01 - $248.82 $246 Million - $277 Million
1,114,788 Added 13.3%
9,494,601 $2.31 Billion
Q4 2020

Feb 12, 2021

BUY
$202.01 - $245.04 $25.9 Million - $31.5 Million
128,384 Added 1.56%
8,379,813 $2.05 Billion
Q3 2020

Nov 13, 2020

SELL
$177.77 - $215.81 $134 Million - $163 Million
-755,327 Reduced 8.39%
8,251,429 $1.72 Billion
Q2 2020

Aug 14, 2020

SELL
$144.67 - $207.03 $36.6 Million - $52.4 Million
-253,153 Reduced 2.73%
9,006,756 $1.62 Billion
Q1 2020

May 15, 2020

SELL
$126.5 - $225.1 $32.3 Million - $57.5 Million
-255,393 Reduced 2.68%
9,259,909 $1.54 Billion
Q4 2019

Feb 18, 2020

SELL
$197.98 - $220.53 $508 Million - $566 Million
-2,568,110 Reduced 21.25%
9,515,302 $2 Billion
Q3 2019

Nov 14, 2019

SELL
$205.4 - $221.82 $122 Million - $132 Million
-594,624 Reduced 4.69%
12,083,412 $2.61 Billion
Q2 2019

Aug 14, 2019

SELL
$180.24 - $205.58 $485 Million - $554 Million
-2,693,589 Reduced 17.52%
12,678,036 $2.61 Billion
Q1 2019

May 15, 2019

BUY
$152.46 - $198.0 $234 Million - $304 Million
1,535,630 Added 11.1%
15,371,625 $3.04 Billion
Q4 2018

Feb 14, 2019

SELL
$145.0 - $178.65 $101 Million - $125 Million
-697,863 Reduced 4.8%
13,835,995 $2.17 Billion
Q3 2018

Nov 14, 2018

SELL
$163.25 - $177.68 $1.47 Billion - $1.6 Billion
-9,014,729 Reduced 38.28%
14,533,858 $2.58 Billion
Q2 2018

Aug 14, 2018

SELL
$155.17 - $179.78 $897 Million - $1.04 Billion
-5,777,611 Reduced 19.7%
23,548,587 $3.98 Billion
Q1 2018

May 15, 2018

SELL
$148.01 - $168.91 $138 Million - $157 Million
-931,963 Reduced 3.08%
29,326,198 $4.72 Billion
Q4 2017

Feb 14, 2018

SELL
$143.51 - $159.74 $86.9 Million - $96.7 Million
-605,590 Reduced 1.96%
30,258,161 $4.69 Billion
Q3 2017

Nov 14, 2017

BUY
$138.36 - $147.87 $4.27 Billion - $4.56 Billion
30,863,751
30,863,751 $4.38 Billion

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $129B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.